Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.

Sarayu SubramanianGang HanNatalie OlsonStanley P LeongMohammed Kashani-SabetRichard L White Jonathan S ZagerVernon K SondakJane L MessinaBarbara PockajHeidi E KosiorekJohn VettoGraham FowlerSchlomo SchneebaumDale Han

Published in: Journal of surgical oncology (2021)

Our data suggest that regression is a favorable prognostic marker in melanoma and predicts significantly better RFS and decreased first-site regional recurrences.

Keyphrases

free survival
skin cancer
electronic health record
big data
machine learning
artificial intelligence
deep learning